NO20030061L - Tyrosinderivater som fosfataseinhibitorer - Google Patents
Tyrosinderivater som fosfataseinhibitorerInfo
- Publication number
- NO20030061L NO20030061L NO20030061A NO20030061A NO20030061L NO 20030061 L NO20030061 L NO 20030061L NO 20030061 A NO20030061 A NO 20030061A NO 20030061 A NO20030061 A NO 20030061A NO 20030061 L NO20030061 L NO 20030061L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- phosphatase inhibitors
- tyrosine derivatives
- diabetes mellitus
- type
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Fats And Perfumes (AREA)
- Furan Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Beskrevet er forbindelser med formel (1) og farmasøytisk akseptable salter og prodrug derav, hvori A, B, R, R, R, Rog Rer som definert i beskrivelsen. Slike forbindelser er tyrosinfosfatascinhibitorer og anvendelig ved behandling og forebygging av Type II Diabetes Mellitus. Også omfattet av oppfinnelsen er formuleringer som innbefatter de angitte forbindelsene, fremgangsmåte for fremstilling av slike forbindelser, og en fremgangsmåte for behandling eller forebygging av Type II Diabetes Mellitus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21620100P | 2000-07-06 | 2000-07-06 | |
PCT/US2001/041271 WO2002004412A2 (en) | 2000-07-06 | 2001-07-05 | Tyrosine derivatives as phosphatase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030061D0 NO20030061D0 (no) | 2003-01-06 |
NO20030061L true NO20030061L (no) | 2003-03-05 |
Family
ID=22806135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030061A NO20030061L (no) | 2000-07-06 | 2003-01-06 | Tyrosinderivater som fosfataseinhibitorer |
Country Status (15)
Country | Link |
---|---|
US (1) | US6586467B2 (no) |
EP (1) | EP1301474B1 (no) |
JP (1) | JP2004502754A (no) |
KR (1) | KR100788510B1 (no) |
AT (1) | ATE407923T1 (no) |
AU (2) | AU2001278188B2 (no) |
BR (1) | BR0112216A (no) |
CA (1) | CA2416220C (no) |
DE (1) | DE60135752D1 (no) |
ES (1) | ES2312461T3 (no) |
IL (2) | IL153804A0 (no) |
MX (1) | MXPA03000166A (no) |
NO (1) | NO20030061L (no) |
NZ (1) | NZ523483A (no) |
WO (1) | WO2002004412A2 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020169157A1 (en) * | 2000-08-29 | 2002-11-14 | Gang Liu | Selective protein tyrosine phosphatatase inhibitors |
US20040191926A1 (en) * | 2001-09-26 | 2004-09-30 | Zhong-Yin Zhang | Ptp1b inhibitors and ligands |
AU2004210711B2 (en) * | 2003-02-12 | 2010-07-08 | Transtech Pharma, Inc. | Substituted azole derivatives as therapeutic agents |
WO2004071448A2 (en) * | 2003-02-12 | 2004-08-26 | Transtech Pharma Inc. | Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
WO2005035551A2 (en) | 2003-10-08 | 2005-04-21 | Incyte Corporation | Inhibitors of proteins that bind phosphorylated molecules |
CN1922151A (zh) * | 2004-02-12 | 2007-02-28 | 特兰斯泰克制药公司 | 取代的吡咯衍生物、组合物和使用方法 |
US7736911B2 (en) * | 2004-04-15 | 2010-06-15 | Albert Einstein College Of Medicine Of Yeshiva University | Activity-based probes for protein tyrosine phosphatases |
NZ569329A (en) | 2006-01-30 | 2011-09-30 | Transtech Pharma Inc | Substituted imidazole derivatives and their use as PTPase inhibitors |
EP2601946A1 (en) * | 2011-12-06 | 2013-06-12 | Pécsi Tudomànyegyetem | Treatment and prevention of diseases related to oxidative stress |
WO2013142010A1 (en) * | 2012-03-20 | 2013-09-26 | Temple University - Of The Commonwealth System Of Higher Education | 3-AMINOTHIENO[3,2-c]QUINOLINE DERIVATIVES, METHODS OF PREPARATION AND USES |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3707559A (en) * | 1971-05-14 | 1972-12-26 | Searle & Co | N-acyl phenylalanine amides |
ES2084176T3 (es) * | 1991-09-05 | 1996-05-01 | Pharno Wedropharm Gmbh | Derivados de sulfonamidas aromaticas, su uso como inhibidores de enzimas y composiciones farmaceuticas que los contienen. |
US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
DE4425781A1 (de) * | 1994-07-14 | 1996-01-18 | Schering Ag | Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel |
DE69824433D1 (en) * | 1997-08-28 | 2004-07-15 | Biovitrum Ab | Proteintyrosinphosphatase inhibitoren |
US6410585B1 (en) * | 1997-08-28 | 2002-06-25 | Scott D. Larsen | Inhibitors of protein tyrosine phosphatase |
JPH11246511A (ja) * | 1998-02-25 | 1999-09-14 | Kanebo Ltd | 硫酸エステル誘導体 |
US6613801B2 (en) * | 2000-05-30 | 2003-09-02 | Transtech Pharma, Inc. | Method for the synthesis of compounds of formula I and their uses thereof |
JP2004531700A (ja) * | 2001-02-05 | 2004-10-14 | グラフィニティー、ファーマスーティカルス アーゲー | 低親和性スクリーニング法 |
-
2001
- 2001-07-05 WO PCT/US2001/041271 patent/WO2002004412A2/en active IP Right Grant
- 2001-07-05 MX MXPA03000166A patent/MXPA03000166A/es active IP Right Grant
- 2001-07-05 AU AU2001278188A patent/AU2001278188B2/en not_active Ceased
- 2001-07-05 KR KR1020037000196A patent/KR100788510B1/ko not_active IP Right Cessation
- 2001-07-05 NZ NZ523483A patent/NZ523483A/en not_active IP Right Cessation
- 2001-07-05 IL IL15380401A patent/IL153804A0/xx unknown
- 2001-07-05 US US09/899,654 patent/US6586467B2/en not_active Expired - Fee Related
- 2001-07-05 BR BR0112216-9A patent/BR0112216A/pt not_active IP Right Cessation
- 2001-07-05 AU AU7818801A patent/AU7818801A/xx active Pending
- 2001-07-05 EP EP01956161A patent/EP1301474B1/en not_active Expired - Lifetime
- 2001-07-05 ES ES01956161T patent/ES2312461T3/es not_active Expired - Lifetime
- 2001-07-05 DE DE60135752T patent/DE60135752D1/de not_active Expired - Lifetime
- 2001-07-05 AT AT01956161T patent/ATE407923T1/de not_active IP Right Cessation
- 2001-07-05 CA CA2416220A patent/CA2416220C/en not_active Expired - Fee Related
- 2001-07-05 JP JP2002509079A patent/JP2004502754A/ja not_active Ceased
-
2003
- 2003-01-05 IL IL153804A patent/IL153804A/en not_active IP Right Cessation
- 2003-01-06 NO NO20030061A patent/NO20030061L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6586467B2 (en) | 2003-07-01 |
EP1301474A2 (en) | 2003-04-16 |
ES2312461T3 (es) | 2009-03-01 |
JP2004502754A (ja) | 2004-01-29 |
US20020040003A1 (en) | 2002-04-04 |
KR100788510B1 (ko) | 2007-12-24 |
CA2416220A1 (en) | 2002-01-17 |
KR20030029613A (ko) | 2003-04-14 |
IL153804A0 (en) | 2003-07-31 |
NO20030061D0 (no) | 2003-01-06 |
IL153804A (en) | 2009-12-24 |
WO2002004412A3 (en) | 2002-08-22 |
AU7818801A (en) | 2002-01-21 |
AU2001278188B2 (en) | 2007-05-17 |
EP1301474B1 (en) | 2008-09-10 |
ATE407923T1 (de) | 2008-09-15 |
CA2416220C (en) | 2010-04-06 |
MXPA03000166A (es) | 2004-09-13 |
NZ523483A (en) | 2004-08-27 |
BR0112216A (pt) | 2004-02-10 |
WO2002004412A2 (en) | 2002-01-17 |
DE60135752D1 (en) | 2008-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO2372B1 (en) | Source drugs of 4-phenylpyridine derivatives | |
WO2002057252A3 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
BR0108893B1 (pt) | composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos. | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
WO2004056786A3 (en) | Pyrimidine derivates for the treatment of abnormal cell growth | |
NO20015172L (no) | 1-metyl-erytromycin-derivater | |
ATE324371T1 (de) | N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten | |
AU2002211216A1 (en) | Substituted aminopropoxyaryl derivatives useful as agonists for lxr | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
DK1263730T3 (da) | Aminderivater til behandling af apoptose | |
MXPA05012837A (es) | Inhibidores de caspasa y usos de los mismos. | |
ES2243579T3 (es) | Derivados de pirazolopirideno. | |
ATE372995T1 (de) | Benzo(b)(1,4)dioxepinderivate | |
MY139612A (en) | Benzoxazine derivatives as 5-th6 modulators and uses thereof | |
NO20030061L (no) | Tyrosinderivater som fosfataseinhibitorer | |
MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
WO2007014839A3 (en) | Cathepsin k inhibitors | |
WO2001081316A3 (en) | Substituted phenyl farnesyltransferase inhibitors | |
DK1109560T3 (da) | Som AICARFT-inhibitorer anvendelige forbindelser | |
DE69933885D1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
WO2003057213A3 (en) | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor | |
DK1301475T3 (da) | Arylsulfonamider, som serotoninantagonist til behandling af obesitet | |
PL390683A1 (pl) | Zastosowanie pochodnych pirolu do wytwarzania leku |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |